COVID-19 treatment being rushed to FDA after trials were 'stopped early due to positive results'
On Friday morning, pharmaceutical firm Merck issued a statement saying that, in consultation with the U.S. Food and Drug Administration (FDA), it has stopped recruiting patients to test its antiviral drug molnupiravir for the prevention of COVID-19. Itโs not stopping because of problems. Itโs stopping because the testing results so far have been so promising that Merck intends to make an immediate application for an Emergency Use Authorization.
Follow
@catlynne333 While that's good news for those that are ill....
I'm concerned that the covidiots and anti-vaxxer crowd will just use it as another reason to avoid getting vaccinated.
@Synical yeah me too